kw 2189 has been researched along with Lung Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asai, A; Iwamoto, Y; Kato, H; Kusaba, H; Mizukami, T; Nakano, H; Nishio, K; Saijo, N; Taguchi, F; Yano, K | 1 |
Funayama, Y; Isogai, Y; Kanzawa, F; Kuraishi, Y; Lee, YS; Nishio, K; Ogasawara, H; Ohira, T; Saijo, N | 1 |
Funayama, Y; Isogai, Y; Kubota, N; Kuraishi, Y; Nishio, K; Ogasawara, H; Ohira, T; Ohmori, T; Saijo, N; Takeda, Y | 1 |
Arioka, H; Fukuoka, K; Ishida, T; Nishio, K; Ogasawara, H; Saijo, N | 1 |
4 other study(ies) available for kw 2189 and Lung Neoplasms
Article | Year |
---|---|
hnRNP L enhances sensitivity of the cells to KW-2189.
Topics: Amino Acid Sequence; Animals; DNA-Binding Proteins; Duocarmycins; Heterogeneous-Nuclear Ribonucleoprotein L; Humans; Lung Neoplasms; Mice; Mutation; Nuclear Proteins; Pyrrolidinones; Ribonucleoproteins; Transfection; Tumor Cells, Cultured | 2004 |
Intracellular carboxyl esterase activity is a determinant of cellular sensitivity to the antineoplastic agent KW-2189 in cell lines resistant to cisplatin and CPT-11.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Carboxylic Ester Hydrolases; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; DNA; Drug Resistance; Drug Resistance, Multiple; Duocarmycins; Female; Humans; Irinotecan; Lung Neoplasms; Microsomes; Ovarian Neoplasms; Pyrrolidinones; Tumor Cells, Cultured | 1995 |
A novel antitumor antibiotic, KW-2189 is activated by carboxyl esterase and induces DNA strand breaks in human small cell lung cancer cells.
Topics: Antibiotics, Antineoplastic; Carboxylic Ester Hydrolases; Carcinoma, Small Cell; Cell Survival; DNA Damage; DNA, Neoplasm; Duocarmycins; Humans; In Vitro Techniques; Lung Neoplasms; Pyrrolidinones; Restriction Mapping; Tumor Cells, Cultured | 1994 |
In vitro enhancement of antitumor activity of a water-soluble duocarmycin derivative, KW-2189, by caffeine-mediated DNA-repair inhibition in human lung cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Caffeine; Carcinoma, Non-Small-Cell Lung; DNA Damage; DNA, Neoplasm; Drug Synergism; Duocarmycins; Humans; Lung Neoplasms; Pyrrolidinones; Solubility; Water | 1997 |